Type 2 Diabetes

People who take a common drug for type 2 diabetes may be at risk for serious drug interactions if they add the blood thinner warfarin to the mix.

Is coffee good for you and your patients? What if it’s decaffeinated or loaded with sugar or cream? A new study adds fuel to the on-going debate.

Researchers say that patients using YouTube videos to obtain advice about their peripheral nerve pain are being misguided about half of the time.

The verdict is in regarding SGLT2 inhibitor use and diabetic ketoacidosis. Expert panel conclusions are summarized.

Three SGLT2 inhibitors have similar drug costs per unit dose, but what are the drug costs based on treatment response?

Changes in gut bacterial growth rates may be linked to onset of diseases, such as type 2 diabetes or irritable bowel syndrome, for example, according to research published in the journal Science.

Researchers sift through risk factors and clinical trial findings to determine if the SGLT2 inhibitor increases bladder cancer risk.

Which GLP-1 receptor agonist showed improved HbAlc with no weight gain or hypoglycemia?

A new analysis of trial data shows that patients with exocrine pancreatic insufficiency benefit about as much from pancrelipase delayed-release capsules (Creon) whether or not they have diabetes mellitus.

Sleep apnea and depression are both serious conditions patients deal with on a daily basis. A recent study looked at a possible connection between the two and how doctors can better treat these patients.

Do added sugars and artificial sweeteners play an equal role in type 2 diabetes risk?

The evidence indicates resistant starches improve glucose metabolism beyond what would be expected from its reduced glycemic index.

We examine the results of various bariatric surgeries on long-term type 2 diabetes control and/or remission.

New research into distal pancreatectomies indicates that women and overweight patients have an elevated risk of suffering endocrine function impairment that leads to glucose intolerance and diabetes mellitus.

A new study turns conventional beliefs about metformin’s main site of action upside down.

New research on the link between diabetes and pancreatitis has shown a strong association between the severity of pancreatic dysfunction and subsequent risk of developing type 2 diabetes mellitus.

With a rallying cry of "Hands off Our Legs" protestors are due to picket the US Department of Health and Human Services over a proposed Medicare rule change that would affect amputees.

Finding more effective therapies for preventing diabetic nephropathy would be attractive, and a recent study has pointed to SGLT2 inhibitors as promising candidates in this area.

“In brief, the risk for T2DM is a combination of both person and place, and our national strategies need to understand and intervene across these levels.”

It may be cool to sip on a Coca-Cola that features your name right on the product, but a report that's been making the rounds details the metabolic roller coaster ride that drinking even a single can unleashes on the body.

Catch up on some of the latest headlines in diabetes care, including updates in pediatric management and an artificial pancreas.

What is the best way to treat a diabetic patient who has a metformin intolerance? Test your knowledge of alternative monotherapies, including SGLT2 inhibitors, GLP-1 agonists, and sulfonylureas.

There are pros and cons to using SGLT2 inhibitors in the elderly. Are you familiar with both? Find out with 7 quick multiple choice questions.

This slideshow presents several tips to keep in mind once ICD-10 goes live.